Statin Drug Warning On Coenzyme Q10 Levels Sought In Lawsuit Against FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Lawsuit follows agency's denial of a citizen petition requesting a warning about coenzyme Q10-depleting effects of cholesterol-lowering drugs. FDA says there is "no reasonable evidence" for concluding that statin-induced decreases in CoQ10 levels are associated with adverse events.